NYSE:HCHC - HC2 Stock Price, News & Analysis

+0.05 (+2.35 %)
(As of 08/19/2019 04:00 PM ET)
Today's Range
Now: $2.18
50-Day Range
MA: $2.16
52-Week Range
Now: $2.18
Volume71,649 shs
Average Volume345,883 shs
Market Capitalization$99.96 million
P/E RatioN/A
Dividend YieldN/A
HC2 Holdings, Inc provides construction, marine services, energy, telecommunications, insurance, life sciences, broadcasting, and other services in the United States, the United Kingdom, and internationally. The company models, details, fabricates, and erects structural steel for commercial and industrial, and infrastructure construction projects, including building and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants. Read More…

Industry, Sector and Symbol

Industry Fabricated structural metal products
SectorMulti-Sector Conglomerates
Previous SymbolNASDAQ:HCHC



Sales & Book Value

Annual Sales$1.98 billion
Cash Flow$0.9604 per share
Book Value$9.40 per share


Net Income$162 million


Market Cap$99.96 million
Next Earnings Date11/6/2019 (Estimated)

Receive HCHC News and Ratings via Email

Sign-up to receive the latest news and ratings for HCHC and its competitors with MarketBeat's FREE daily newsletter.

HC2 (NYSE:HCHC) Frequently Asked Questions

What is HC2's stock symbol?

HC2 trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCHC."

How were HC2's earnings last quarter?

HC2 Holdings Inc (NYSE:HCHC) announced its quarterly earnings data on Tuesday, May, 7th. The technology company reported ($0.04) EPS for the quarter, topping the Zacks' consensus estimate of ($0.55) by $0.51. The technology company earned $491.40 million during the quarter, compared to the consensus estimate of $479.65 million. HC2 had a return on equity of 2.27% and a net margin of 7.28%. View HC2's Earnings History.

When is HC2's next earnings date?

HC2 is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for HC2.

What price target have analysts set for HCHC?

1 brokerages have issued 12 month target prices for HC2's stock. Their forecasts range from $11.00 to $11.00. On average, they anticipate HC2's stock price to reach $11.00 in the next twelve months. This suggests a possible upside of 404.6% from the stock's current price. View Analyst Price Targets for HC2.

What is the consensus analysts' recommendation for HC2?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HC2 in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HC2.

Has HC2 been receiving favorable news coverage?

Media coverage about HCHC stock has been trending negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HC2 earned a daily sentiment score of -2.3 on InfoTrie's scale. They also gave media stories about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for HC2.

Are investors shorting HC2?

HC2 saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 4,450,600 shares, an increase of 6.4% from the June 30th total of 4,182,000 shares. Based on an average daily volume of 351,600 shares, the short-interest ratio is currently 12.7 days. Approximately 11.1% of the company's shares are sold short. View HC2's Current Options Chain.

Who are some of HC2's key competitors?

What other stocks do shareholders of HC2 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HC2 investors own include Ford Motor (F), General Electric (GE), Aurora Cannabis (ACB), Opko Health (OPK), Gemphire Therapeutics (GEMP), Intel (INTC), Micron Technology (MU), Allena Pharmaceuticals (ALNA), Celgene (CELG) and Gilead Sciences (GILD).

Who are HC2's key executives?

HC2's management team includes the folowing people:
  • Mr. Philip Alan Falcone, Chairman, Pres & CEO (Age 57)
  • Mr. Michael J. Sena, Chief Financial Officer (Age 46)
  • Mr. Joseph A. Ferraro J.D., Chief Legal Officer & Corp. Sec. (Age 41)
  • Mr. Paul L. Robinson, Consultant (Age 52)
  • Ms. Suzi Raftery Herbst, Chief Admin. Officer (Age 43)

Who are HC2's major shareholders?

HC2's stock is owned by many different of institutional and retail investors. Top institutional shareholders include B. Riley Financial Inc. (9.37%), Vanguard Group Inc. (2.91%), Raging Capital Management LLC (1.94%), BlackRock Inc. (1.66%), Equitec Specialists LLC (1.62%) and Teton Advisors Inc. (1.62%). Company insiders that own HC2 stock include Michael J Sena, Philip Falcone, Robert V Leffler Jr, Suzi R Herbst and Wayne Barr Jr. View Institutional Ownership Trends for HC2.

Which institutional investors are selling HC2 stock?

HCHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., Vanguard Group Inc., B. Riley Financial Inc., Invesco Ltd., Bank of New York Mellon Corp, Gabelli Funds LLC and Ancora Advisors LLC. View Insider Buying and Selling for HC2.

Which institutional investors are buying HC2 stock?

HCHC stock was purchased by a variety of institutional investors in the last quarter, including Raging Capital Management LLC, VIEX Capital Advisors LLC, Russell Investments Group Ltd., Paloma Partners Management Co, Jane Street Group LLC, Equitec Specialists LLC, Acadian Asset Management LLC and Man Group plc. Company insiders that have bought HC2 stock in the last two years include Michael J Sena, Philip Falcone, Suzi R Herbst and Wayne Barr Jr. View Insider Buying and Selling for HC2.

How do I buy shares of HC2?

Shares of HCHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HC2's stock price today?

One share of HCHC stock can currently be purchased for approximately $2.18.

How big of a company is HC2?

HC2 has a market capitalization of $99.96 million and generates $1.98 billion in revenue each year. The technology company earns $162 million in net income (profit) each year or ($0.82) on an earnings per share basis. HC2 employs 4,119 workers across the globe.View Additional Information About HC2.

What is HC2's official website?

The official website for HC2 is http://www.hc2.com/.

How can I contact HC2?

HC2's mailing address is 450 PARK AVENUE 30TH FLOOR, NEW YORK NY, 10022. The technology company can be reached via phone at 212-235-2690 or via email at [email protected]

MarketBeat Community Rating for HC2 (NYSE HCHC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  224 (Vote Outperform)
Underperform Votes:  197 (Vote Underperform)
Total Votes:  421
MarketBeat's community ratings are surveys of what our community members think about HC2 and other stocks. Vote "Outperform" if you believe HCHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel